OnePin Peptide Library · Metabolic
Metformin
Glucophage · Metformin HCl · Metformin XR
Metformin (dimethylbiguanide) is the most widely prescribed oral medication for type 2 diabetes worldwide, with over 150 million prescriptions annually. First approved in Europe in 1957 and by the FDA in 1995, it remains the first-line pharmacotherapy for type 2 diabetes per ADA guidelines. Metformin is derived from the French lilac (Galega officinalis), a plant used in medieval European folk medicine for diabetes symptoms.,Beyond diabetes, metformin has generated enormous interest in the longevity and biohacking communities as a potential anti-aging compound. Observational data suggests metformin users have lower all-cause mortality than non-diabetic controls (Bannister et al. 2014), and the TAME (Targeting Aging with Metformin) trial - the first FDA-approved clinical trial to test a drug specifically for aging - launched in 2024 to evaluate metformin's effects on age-related diseases.,Metformin activates AMPK, inhibits mitochondrial Complex I, reduces hepatic gluconeogenesis, and modulates the gut microbiome. Its anti-aging mechanisms are hypothesized to involve reduced mTOR signaling, decreased inflammation and oxidative stress, improved autophagy, and cellular stress response mimicry. However, metformin may blunt exercise-induced mitochondrial adaptations, creating a nuanced risk-benefit profile for athletes and fitness enthusiasts.
Take with meals to reduce GI side effects. Start low (500mg with dinner) and titrate up over 2-4 weeks. Extended-release (ER) formulation significantly reduces GI side effects. Take evening dose for maximum overnight glucose suppression.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
Metformin's primary action is inhibition of mitochondrial Complex I in hepatocytes, which increases the AMP:ATP ratio and activates AMPK. Activated AMPK suppresses hepatic gluconeogenesis (the liver's production of new glucose), which accounts for metformin's main glucose-lowering effect. Unlike sulfonylureas or insulin, metformin does not cause hypoglycemia in non-diabetics because it does not stimulate insulin secretion.,Additional metabolic effects include enhanced peripheral glucose uptake in skeletal muscle (via GLUT4 translocation), reduced intestinal glucose absorption, improved insulin receptor sensitivity, and modulation of the gut microbiome (increased Akkermansia muciniphila, improved short-chain fatty acid production). GLP-1 secretion is also enhanced, contributing to improved glucose-dependent insulin release.,Anti-aging mechanisms are multifaceted: AMPK activation inhibits mTOR signaling (the same pathway targeted by rapamycin), promoting autophagy and cellular housekeeping. Metformin reduces systemic inflammation (lower CRP, IL-6, TNF-alpha), decreases oxidative stress, improves mitochondrial function, and activates cellular stress response pathways (hormesis). These effects collectively mimic aspects of caloric restriction - the most robust intervention for extending lifespan in animal models.
Metformin's primary action is inhibition of mitochondrial Complex I in hepatocytes, which increases the AMP:ATP ratio and activates AMPK. Activated AMPK suppresses hepatic gluconeogenesis (the liver's production of new glucose), which accounts for metformin's main glucose-lowering effect. Unlike sulfonylureas or insulin, metformin does not cause hypoglycemia in non-diabetics because it does not stimulate insulin secretion.,Additional metabolic effects include enhanced peripheral glucose uptake in skeletal muscle (via GLUT4 translocation), reduced intestinal glucose absorption, improved insulin receptor sensitivity, and modulation of the gut microbiome (increased Akkermansia muciniphila, improved short-chain fatty acid production). GLP-1 secretion is also enhanced, contributing to improved glucose-dependent insulin release.,Anti-aging mechanisms are multifaceted: AMPK activation inhibits mTOR signaling (the same pathway targeted by rapamycin), promoting autophagy and cellular housekeeping. Metformin reduces systemic inflammation (lower CRP, IL-6, TNF-alpha), decreases oxidative stress, improves mitochondrial function, and activates cellular stress response pathways (hormesis). These effects collectively mimic aspects of caloric restriction - the most robust intervention for extending lifespan in animal models.
What to expect
Weeks 1-2: GI adjustment period. Early blood glucose improvements.
Evidence
Interactions & stacking
What's safe to combine, and what belongs in a separate pin.
Safe & synergistic
Keep separate
Pharmacokinetics
Storage. Store at room temperature (20-25C). Protect from light and moisture. Extended-release tablets should not be crushed or split. Shelf life typically 2-3 years. No special storage requirements.
Regulatory status
FDA-approved prescription medication for type 2 diabetes mellitus (Glucophage, generic). Off-label use for prediabetes, PCOS, weight management, and longevity. Prescription required in the US. One of the most affordable prescription medications available. WHO Essential Medicine.
Put it to work
Calculate, log & track
Open Metformin straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Metformin in the app →Go deeper
The guide & community
The complete Metformin walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗